A Phase 1 trial of IMC U120AI in atopic dermatitis
Latest Information Update: 16 Jan 2025
Price :
$35 *
At a glance
- Drugs IMC U120AI (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- 16 Jan 2025 New trial record
- 10 Jan 2025 According to Immunocore media release, Company plans to file a CTA in 2026 for a Phase 1 trial in atopic dermatitis.